Michael Wolff was at the "edge of a cliff" when he was diagnosed with a cancer that affects less than 300 patients a year in ...

Hoag Memorial Hospital Presbyterian has named a renowned expert specializing in gastrointestinal cancer as the new executive ...

Taxane chemotherapy is unable to sensitize prostate cancer to immune checkpoint inhibitors, resulting in another negative trial with immunotherapy in prostate cancer,” said Andrea Necchi, MD.

This author is the Editor-in-Chief of Journal of Clinical Oncology. Journal policy recused the author from having any role in the peer review of this manuscript.

A new study published in the journal of Renal Failure showed that patients with chronic obstructive pulmonary disease (COPD) ...

Laura Landro is a former Wall Street Journal Informed Patient columnist and assistant managing editor. She is the author of "Survivor: Taking Control of Your Fight Against Cancer." ...

Researchers from University of California San Diego have linked a bacterial toxin called colibactin to the increase in ...

Overall, rates of new cancer diagnoses and cancer-related deaths have declined, according to the annual cancer statistics ...

Lies, feckless government oversight, and the participation of nearly every oncologist and cancer hospital ... when a study in the Lancet medical journal came to the shocking conclusion that ...

A new study published in the journal of Stroke showed that the most common cause of young-onset cryptogenic ischemic stroke ...

The primary endpoint was the mean normalcy of diet score on the clinician-rated Performance Status Scale for Head and Neck at 1 year. The mean score was 91.6 in the dose-reduction arm and 92.6 in the ...

The field of gynecologic oncology has seen remarkable progress in recent years, driven by technological innovations and the integration of multidisciplinary ...